Article

Telefonica collaborates with Fundacion Vithas and Francisco de Vitoria University to apply quantum computing in cancer drug development. The project will be showcased at MWC26 Barcelona. It employs a hybrid model of classical and quantum computing to design molecules targeting mutations linked to malignant tumors, significantly reducing research times compared to traditional methods.